Recipharm AB (publ) Competitors

Recipharm AB (publ) (OTCMKTS:RCPHF) and (DDXS) (OTCMKTS:DDXS) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, institutional ownership, risk, dividends, earnings and profitability.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Recipharm AB (publ) and (DDXS), as reported by MarketBeat.

Profitability

This table compares Recipharm AB (publ) and (DDXS)'s net margins, return on equity and return on assets.

Earnings and Valuation

This table compares Recipharm AB (publ) and (DDXS)'s gross revenue, earnings per share and valuation.

Summary

Recipharm AB (publ) beats (DDXS) on 1 of the 1 factors compared between the two stocks.

Recipharm AB (publ) (OTCMKTS:RCPHF) and (TNGN) (OTCMKTS:TNGN) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, institutional ownership, risk, dividends, earnings and profitability.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Recipharm AB (publ) and (TNGN), as reported by MarketBeat.

Profitability

This table compares Recipharm AB (publ) and (TNGN)'s net margins, return on equity and return on assets.

Earnings and Valuation

This table compares Recipharm AB (publ) and (TNGN)'s gross revenue, earnings per share and valuation.

Summary

Recipharm AB (publ) beats (TNGN) on 1 of the 1 factors compared between the two stocks.

Recipharm AB (publ) (OTCMKTS:RCPHF) and Abattis Bioceuticals (OTCMKTS:ATTBF) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, institutional ownership, risk, dividends, earnings and profitability.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Recipharm AB (publ) and Abattis Bioceuticals, as reported by MarketBeat.

Profitability

This table compares Recipharm AB (publ) and Abattis Bioceuticals' net margins, return on equity and return on assets.

Earnings and Valuation

This table compares Recipharm AB (publ) and Abattis Bioceuticals' gross revenue, earnings per share and valuation.

Summary

Recipharm AB (publ) beats Abattis Bioceuticals on 1 of the 1 factors compared between the two stocks.

Recipharm AB (publ) (OTCMKTS:RCPHF) and ADiTx Therapeutics (NASDAQ:ADTX) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, institutional ownership, risk, dividends, earnings and profitability.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Recipharm AB (publ) and ADiTx Therapeutics, as reported by MarketBeat.

Profitability

This table compares Recipharm AB (publ) and ADiTx Therapeutics' net margins, return on equity and return on assets.

Earnings and Valuation

This table compares Recipharm AB (publ) and ADiTx Therapeutics' gross revenue, earnings per share and valuation.

Recipharm AB (publ) (OTCMKTS:RCPHF) and Algernon Pharmaceuticals (OTCMKTS:AGNPF) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, institutional ownership, risk, dividends, earnings and profitability.

Earnings and Valuation

This table compares Recipharm AB (publ) and Algernon Pharmaceuticals' gross revenue, earnings per share and valuation.

Profitability

This table compares Recipharm AB (publ) and Algernon Pharmaceuticals' net margins, return on equity and return on assets.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Recipharm AB (publ) and Algernon Pharmaceuticals, as reported by MarketBeat.

Summary

Recipharm AB (publ) beats Algernon Pharmaceuticals on 1 of the 1 factors compared between the two stocks.

Almirall (OTCMKTS:LBTSF) and Recipharm AB (publ) (OTCMKTS:RCPHF) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, analyst recommendations, earnings, profitability, valuation and dividends.

Valuation and Earnings

This table compares Almirall and Recipharm AB (publ)'s gross revenue, earnings per share and valuation.

Profitability

This table compares Almirall and Recipharm AB (publ)'s net margins, return on equity and return on assets.

Analyst Ratings

This is a breakdown of current ratings and target prices for Almirall and Recipharm AB (publ), as reported by MarketBeat.com.

Summary

Recipharm AB (publ) beats Almirall on 1 of the 1 factors compared between the two stocks.